Rapport Therapeutics, Inc. (RAPP) income statement
RAPPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$23.16−0.43 (-1.82%)
Close on Nov 20, 2026Market cap $1.11BP/E –Yield –
Rapport Therapeutics, Inc. financial ratios
See a number that looks wrong?